|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
Q4 FY2011
As of Dec 31, 2011
|
Q3 FY2011
As of Sep 30, 2011
|
Q2 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Land | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total land | ||||||||||||||||||
| Land Under Development | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total land Under Development | ||||||||||||||||||
| Buildings and Improvements | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total buildings and Improvements | ||||||||||||||||||
| Construction in Progress | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total construction in Progress | ||||||||||||||||||
| Real Estate Investment Property, at Cost | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total real Estate Investment Property, at Cost | ||||||||||||||||||
| Real Estate Investment Property, Accumulated Depreciation | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total real Estate Investment Property, Accumulated Depreciation | ||||||||||||||||||
| Investments in real estate, net | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total investments in real estate, net | ||||||||||||||||||
| Investments in unconsolidated partnerships | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total investments in unconsolidated partnerships | ||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||
| Accrued straight-line rents, net | ||||||||||||||||||
| Deferred leasing costs, net | ||||||||||||||||||
| Other assets | ||||||||||||||||||
| Total assets | ||||||||||||||||||
| Liabilities and Equity | ||||||||||||||||||
| Liabilities | ||||||||||||||||||
| Mortgage notes payable, net | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Exchangeable senior notes | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Unsecured senior notes, net | ||||||||||||||||||
| Unsecured Debt | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Unsecured senior term loans | ||||||||||||||||||
| Unsecured Debt | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Unsecured line of credit | ||||||||||||||||||
| Unsecured Line of Credit | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Accounts payable, accrued expenses and other liabilities | ||||||||||||||||||
| Total liabilities | ||||||||||||||||||
| Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | ||||||||||||||||||
| Preferred stock, $.01 par value, 15,000,000 shares authorized: 7.375% Series A cumulative redeemable preferred stock, no shares issued and outstanding at December 31, 2013; and 7,920,000 shares issued and outstanding at December 31, 2012, $198,000 liquidation preference ($25.00 per share) | ||||||||||||||||||
| Limited partners' capital, 5,398,224 and 5,405,474 units issued and outstanding at September 30, 2015 and December 31, 2014, respectively | ||||||||||||||||||
| General partner's capital, 203,527,787 and 197,442,432 units issued and outstanding at September 30, 2015 and December 31, 2014, respectively | ||||||||||||||||||
| Common stock, $.01 par value, 300,000,000 shares and 250,000,000 shares authorized, and 203,527,787 shares and 197,442,432 shares issued and outstanding at September 30, 2015 and December 31, 2014, respectively | ||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total partners' capital | ||||||||||||||||||
| Dividends in excess of earnings | ||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||
| Noncontrolling interests / Noncontrolling interests deficit | ||||||||||||||||||
| Parent Company | ||||||||||||||||||
| BIOMED REALTY, L.P. | ||||||||||||||||||
| Total equity / capital | ||||||||||||||||||
| Total liabilities and equity / capital | ||||||||||||||||||
Loading...